Environment and Infectious Risks
A synthetic glycopeptide for anti-tumor immunotherapy: from design to first use in human
NéoVac (Neonatal Vaccination against Hepatitis B in Africa)
Yusuke Shimakawa • Muriel Vray
Role of human polymorphisms in nicotinic receptors in lung cancer and COPD
Regulation of retroviral infections
Françoise Barre-Sinoussi • Daniel Scott-Algara • Laurence Weiss
Mathematical Modelling Of Infectious Diseases
Birgit Nikolay joined the MMMI unit as PostDoc in September 2015. Her main research interest is the investigation of infectious disease emergence in human populations, from spillovers to interhuman transmission and outbreak management, and […]
Cellular and molecular immunoprofiling of multiple sclerosis patients
ANRS 12332 HepNile: Evaluation of “Real Life” Efficacy and Safety of antiviral treatments including new Direct Antiviral Agents among patients treated for Chronic Hepatitis C at Egyptian National Treatment Centres
Establishment of new humanized mice and chronic human diseases.
Regulation of innate CD8 memory T cells during Salmonella typhimurium infection.
Global and Tropical Infectious Diseases ; ADNA Program Department, Bio-mérieux